Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Bleaching hair damages protein structure, especially keratin, leading to weakened hair.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

HAT-L4 is crucial for preventing body fluid loss by maintaining skin barrier integrity.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Rabbits lacking the Hoxc13 gene show similar hair and skin issues to humans with ECTD-9, making them good for research on this condition.

Rectangular black granules, solitary yellow dots, and mostly single-hair follicles suggest Loose Anagen Hair Syndrome.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

A 2-year-old boy with a rare brain malformation may have Gomez–López-Hernández syndrome.

Lupus can cause hair loss and nail changes, with treatments available for both.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

A mutation in the Adam10 gene causes freckle-like spots on Hairless mice.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Cedrol Nanoemulsion was found to be more effective at promoting hair growth than traditional treatments and had better bioavailability.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.